Marco Lyons

In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model

R. Carare, R. Gieschke, Szofia Bullain, 2022, Alzheimer's & dementia.

Comparing ARIA‐E severity scales and effects of treatment management thresholds

Marzia A. Scelsi, F. Barkhof, J. Suhy, 2022, Alzheimer's & dementia.

Comparing ARIA‐E severity scales and effects of treatment management thresholds

Marzia A. Scelsi, F. Barkhof, J. Suhy, 2022 .

Validation of 3‐ and 5‐point severity scales to assess ARIA‐E

Marzia A. Scelsi, J. Suhy, Szofia Bullain, 2023, Alzheimer's & dementia.